JESSIAN MUNOZ to Case-Control Studies
This is a "connection" page, showing publications JESSIAN MUNOZ has written about Case-Control Studies.
Connection Strength
1.064
-
Identification and stratification of placenta percreta with gynecologic oncologist management. Int J Gynecol Cancer. 2025 Jun; 35(6):101859.
Score: 0.138
-
Surgical Outcomes and Associated Morbidity of Active and Expectant Management of Second-Trimester Placenta Accreta Spectrum (PAS). Medicina (Kaunas). 2025 Jan 14; 61(1).
Score: 0.136
-
Risk factors for intensive care unit admission after cesarean hysterectomy for placenta accreta spectrum. Int J Gynaecol Obstet. 2024 Nov; 167(2):656-662.
Score: 0.130
-
Association between Antenatal Vaginal Bleeding and Adverse Perinatal Outcomes in Placenta Accreta Spectrum. Medicina (Kaunas). 2024 Apr 22; 60(4).
Score: 0.129
-
Risk factors of massive blood transfusion (MTP) in cesarean hysterectomy for placenta accreta spectrum. Eur J Obstet Gynecol Reprod Biol. 2024 Feb; 293:32-35.
Score: 0.126
-
Impact of placenta accreta spectrum (PAS) pathology on neonatal respiratory outcomes in cesarean hysterectomies. J Matern Fetal Neonatal Med. 2022 Dec; 35(26):10692-10697.
Score: 0.118
-
Short interval pregnancy is associated with pathology severity in placenta accreta spectrum (PAS). J Matern Fetal Neonatal Med. 2022 Dec; 35(25):8863-8868.
Score: 0.109
-
Neuraxial to general anesthesia conversion has equitable intraoperative and improved post-operative outcomes compared to general anesthesia in cesarean hysterectomy for placenta accreta spectrum (PAS). J Matern Fetal Neonatal Med. 2022 Dec; 35(25):8640-8644.
Score: 0.109
-
Diagnostic Value of Cell-Free DNA Fetal Fraction in Patients With Prenatally Suspected Placenta Accreta Spectrum Disorder. Prenat Diagn. 2025 08; 45(9):1160-1166.
Score: 0.035
-
Adverse outcomes in monochorionic twins with amniotic fluid abnormalities without TTTS: A Case-Control study. Eur J Obstet Gynecol Reprod Biol. 2025 Mar; 306:132-138.
Score: 0.034